Monday's encouraging coronavirus vaccine news from Pfizer Inc. sparked a rally in aerospace stocks. Even after Monday's rally, the group is "more investable" — and investor interest will grow, according to JPMorgan. Raytheon (NYSE: RTX) is a combined aerospace and defense company, but the aerospace unit will "dominate" a valuation expansion as the sector recovers in the coming years, he said. J.P. Morgan analyst Seth Seifman raised the recommendation on Raytheon Technologies Corp. to overweight from neutral. Price target set to $79, implies a 22% increase from last price.